MetaStat is a life science company operating through its subsidiary MetaStat BioMedical to develop and commercialize proprietary clinical diagnostic tests that predict the probability of blood borne systemic metastasis of cancer; and therapeutics to prevent systemic metastasis. Its products include MetaSite Breast test; MenaCalc Breast test; MenaCalc Lung test; MenaCalc Prostate test; and MenaBloc therapeutics to reduce or eliminate metastasis. For further information, visit the company’s Web site at www.metastat.com

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its ninth annual equity conference at The Hard Rock Hotel in Ft. Lauderdale, FL. Attended by institutional investors from across North America, the event features 135 public company executive teams with an emphasis on healthcare, technology, defense, and new-media / entertainment sectors.

Let us hear your thoughts below: